Risk stratification applied to CAST registry data: Combining 9 predictors

被引:8
作者
Church, TR
Hodges, M
Bailey, JJ
Mongin, SJ
机构
[1] Univ Minnesota, Sch Publ Hlth, Div Environm & Occupat Med, Minneapolis, MN 55455 USA
[2] Minneapolis Heart Inst Fdn, Res Grp, Minneapolis, MN USA
[3] NIH, Ctr Informat Technol, Bethesda, MD 20892 USA
关键词
risk stratification; sudden cardiac death; ejection fraction; multivariate methods;
D O I
10.1054/jelc.2002.37168
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Over 200,000 people in the United States die of sudden cardiac death (SCD) every year. Although many of these deaths occur in asymptomatic individuals, the vast majority of deaths occur in people who are under care for existing coronary heart disease. Implantable cardioverter/defibrillators (ICDs) have been shown in several randomized trials to be effective in prolonging lives of those at high risk for sudden cardiac death, but the criteria used in these trials and the ACC/AHA consensus guidelines would cover only a minority of patients. Developing methods to assign risk to individual patients without prior SCD events could promote the use of this life-saving therapy in those with especially high risk. Given sufficient physiologically relevant measurements from electrocardiogram analysis, clinical assessment, and demographic status, multivariate statistical methods for predicting survival can be used to combine many predictors of risk and calculate the risk for an individual patient. A survival analysis using Cox regression on data from the Cardiac Arrhythmia Suppression Trial (CAST) illustrates this concept. Patient age, sex, ejection fraction, smoking history, and prior myocardial infarction history, along with the frequency of premature beats and the presence of runs of ventricular tachycardia on Holter monitoring and the time from the index myocardial infarction to the baseline Holter and to recruitment into CAST were combined in a multivariate predictor derived from the Cox regression; this predictor significantly outperforms the individual predictors. A proposed test based on this predictor would identify as positive 7% of the CAST registry, with an average, risk of death among the positives of 47%; 20% of those dead at 2 years would be positive. With improved component measurements, this approach has the potential for significantly improving risk stratification for the prevention of SCD.
引用
收藏
页码:117 / 122
页数:6
相关论文
共 24 条
[1]  
CANNER PL, 1980, NEW ENGL J MED, V303, P1038
[2]  
CHURCH T, 2000, RISK ARRHYTHMIA SUDD, P19
[3]   Risk assessment and risk stratification in sudden cardiac death: A biostatistician's view [J].
Church, TR .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1997, 20 (10) :2520-2532
[4]   Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials [J].
Connolly, SJ ;
Hallstrom, AP ;
Cappato, R ;
Schron, EB ;
Kuck, KH ;
Zipes, DP ;
Greene, HL ;
Boczor, S ;
Domanski, M ;
Follmann, D ;
Gent, M ;
Roberts, RS .
EUROPEAN HEART JOURNAL, 2000, 21 (24) :2071-2078
[5]  
CORNFIELD J, 1962, FED PROC, V21, P58
[6]  
COX DR, 1972, J R STAT SOC B, V34, P187
[7]   Treatment of sudden cardiac death - Current understandings from randomized trials and future research directions [J].
Domanski, MJ ;
Zipes, DP ;
Schron, E .
CIRCULATION, 1997, 95 (12) :2694-2699
[8]  
Domanski MJ, 1998, J ELECTROCARDIOL, V31, P47
[9]   MORTALITY AND MORBIDITY IN PATIENTS RECEIVING ENCAINIDE, FLECAINIDE, OR PLACEBO - THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL [J].
ECHT, DS ;
LIEBSON, PR ;
MITCHELL, LB ;
PETERS, RW ;
OBIASMANNO, D ;
BARKER, AH ;
ARENSBERG, D ;
BAKER, A ;
FRIEDMAN, L ;
GREENE, HL ;
HUTHER, ML ;
RICHARDSON, DW .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (12) :781-788
[10]  
Efron B., 1993, INTRO BOOTSTRAP, V1st ed., DOI DOI 10.1201/9780429246593